مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,009
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PHARMACOLOGICAL TREATMENT OF NEUROPATHIC PAIN

Pages

  169-182

Abstract

 Background: NEUROPATHIC PAIN results from injury to or dysfunction of the central or peripheral nervous system. DIABETIC PERIPHERAL NEUROPATHY, post-herpetic neuralgia, and TRIGEMINAL NEURALGIA are among the most common types of NEUROPATHIC PAIN. Patients with these types of pain usually suffer from localized symptoms such as constant or intermittent paresthesia, tingling, burning sensation or spontaneous pain. NEUROPATHIC PAIN is an unpleasant sensation and experience that could adversely affect the quality of life of patients. They often responds to treatment with difficulty and based on the current treatments, only 40 to 60% of patients with NEUROPATHIC PAIN achieve partial relief. Antidepressants (tricyclics and serotoninnorepinephrine reuptake inhibitors), ligand of calcium channelα2-δ subunits (gabapentin and pregabalin) and topical lidocaine have been considered as the first-line therapy for NEUROPATHIC PAIN. Opioid analgrsics and tramadol are generally recommended as the secondline therapy. Other agents such as antiepileptics (e.g. carbamazepine), antagonists of N-Methyl-D-aspartate receptor (e.g. memantine, dextromethorpham), and topical capsaicin have been mainly classified as the third-line treatment for NEUROPATHIC PAIN. Due to the importance of NEUROPATHIC PAIN, reviewing its novel nonpharmacological and pharmacological modalities seems necessary.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    TARAZ, MOHAMMAD, KARIMZADEH, IMAN, & KHALILI, HOSSEIN. (2012). PHARMACOLOGICAL TREATMENT OF NEUROPATHIC PAIN. JOURNAL OF MEDICAL COUNCIL OF I.R.I., 30(2), 169-182. SID. https://sid.ir/paper/41087/en

    Vancouver: Copy

    TARAZ MOHAMMAD, KARIMZADEH IMAN, KHALILI HOSSEIN. PHARMACOLOGICAL TREATMENT OF NEUROPATHIC PAIN. JOURNAL OF MEDICAL COUNCIL OF I.R.I.[Internet]. 2012;30(2):169-182. Available from: https://sid.ir/paper/41087/en

    IEEE: Copy

    MOHAMMAD TARAZ, IMAN KARIMZADEH, and HOSSEIN KHALILI, “PHARMACOLOGICAL TREATMENT OF NEUROPATHIC PAIN,” JOURNAL OF MEDICAL COUNCIL OF I.R.I., vol. 30, no. 2, pp. 169–182, 2012, [Online]. Available: https://sid.ir/paper/41087/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top